BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18027596)

  • 21. [Anticipated changes in the management of anesthesia with use of remifentanil--its clinical application in comparison with fentanyl and morphine].
    Sato K
    Masui; 2007 Nov; 56(11):1274-80. PubMed ID: 18027595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remifentanil and other opioids.
    Servin FS; Billard V
    Handb Exp Pharmacol; 2008; (182):283-311. PubMed ID: 18175097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Remifentanil in general anesthesia].
    Makita K
    Masui; 2007 Nov; 56(11):1268-73. PubMed ID: 18027594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
    Bienert A; Wiczling P; Zaba C; Zaba Z; Wolc A; Marciniak R; Grześkowiak E; Kusza K
    Arzneimittelforschung; 2011; 61(10):545-52. PubMed ID: 22164962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remifentanil: a review of its use during the induction and maintenance of general anaesthesia.
    Scott LJ; Perry CM
    Drugs; 2005; 65(13):1793-823. PubMed ID: 16114980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is remifentanil an ideal opioid for anesthesiologic management in the 21st century?].
    Scholz J; Steinfath M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Dec; 31(10):592-607. PubMed ID: 9081416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.
    Egan TD; Minto CF; Hermann DJ; Barr J; Muir KT; Shafer SL
    Anesthesiology; 1996 Apr; 84(4):821-33. PubMed ID: 8638836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).
    Glass PS; Hardman D; Kamiyama Y; Quill TJ; Marton G; Donn KH; Grosse CM; Hermann D
    Anesth Analg; 1993 Nov; 77(5):1031-40. PubMed ID: 8105723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs.
    Hoke JF; Cunningham F; James MK; Muir KT; Hoffman WE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):226-32. PubMed ID: 9103501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics and pharmacodynamics of remifentanil in volunteers with severe hepatic or renal dysfunction.
    Dershwitz M; Rosow CE
    J Clin Anesth; 1996 May; 8(3 Suppl):88S-90S. PubMed ID: 8695124
    [No Abstract]   [Full Text] [Related]  

  • 31. Remifentanil.
    Patel SS; Spencer CM
    Drugs; 1996 Sep; 52(3):417-27; discussion 428. PubMed ID: 8875131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model.
    Cox EH; Langemeijer MW; Gubbens-Stibbe JM; Muir KT; Danhof M
    Anesthesiology; 1999 Feb; 90(2):535-44. PubMed ID: 9952162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remifentanil in critically ill cardiac patients.
    Ruggeri L; Landoni G; Guarracino F; Scolletta S; Bignami E; Zangrillo A
    Ann Card Anaesth; 2011; 14(1):6-12. PubMed ID: 21196668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of remifentanil on biliary tract drainage into the duodenum.
    Fragen RJ; Vilich F; Spies SM; Erwin WD
    Anesth Analg; 1999 Dec; 89(6):1561-4. PubMed ID: 10589649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics.
    Hermann DJ; Egan TD; Muir KT
    Clin Pharmacol Ther; 1999 May; 65(5):511-8. PubMed ID: 10340916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease.
    Dershwitz M; Hoke JF; Rosow CE; Michałowski P; Connors PM; Muir KT; Dienstag JL
    Anesthesiology; 1996 Apr; 84(4):812-20. PubMed ID: 8638835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers.
    Hoke JF; Shlugman D; Dershwitz M; Michałowski P; Malthouse-Dufore S; Connors PM; Martel D; Rosow CE; Muir KT; Rubin N; Glass PS
    Anesthesiology; 1997 Sep; 87(3):533-41. PubMed ID: 9316957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remifentanil; from pharmacological properties to clinical practice.
    Servin F
    Adv Exp Med Biol; 2003; 523():245-60. PubMed ID: 15088856
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol.
    Vuyk J
    J Clin Anesth; 1997 Sep; 9(6 Suppl):23S-26S. PubMed ID: 9278851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty.
    Standing JF; Hammer GB; Sam WJ; Drover DR
    Paediatr Anaesth; 2010 Jan; 20(1):7-18. PubMed ID: 19825011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.